CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Eric will join a panel discussion on the challenges facing personalized medicine at a featured Personalized Medicine Coalition event at the North Carolina Biotechnology Center on November 16.
News | 11. 03. 2011
Eric will join a panel discussion on the challenges facing personalized medicine at a featured Personalized Medicine Coalition event at the North Carolina Biotechnology Center on November 16.
